Switching From Adalimumab to Infliximab
NCT01338740
·
clinicaltrials.gov ↗
COMPLETED
Status
21
Enrollment
OTHER
Sponsor class
Conditions
Crohn's Disease
Interventions
DRUG:
Adalimumab and Infliximab
Sponsor
University Hospital, Ghent
Collaborators
[object Object]